Shares of Moderna, Inc. plunged over 20% on Monday to their lowest levels since mid-April 2020 and were on course to mark ...
Moderna's stock plummeted to an almost five-year low after the biotech company cut its revenue outlook for this year and said that sales for last year will come in at the lower end of its guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback